Netherlands vs Spain: Access to anti-retroviral drugs, female
Netherlands
89.0%
in 2023
Spain
89.0%
in 2022
Netherlands rank
35th
Spain rank
35th
Access to anti-retroviral drugs, female over time
- Netherlands
- Spain
How they compare
Netherlands currently reports 89.0% against 89.0% in Spain, a difference of 0.0%.
The two have swapped places 1 time across 23 shared years of data; in 2000 it was Netherlands ahead.
Netherlands ranks 35th and Spain ranks 35th of 141 countries.
Across the 3 decades both report, Netherlands averaged higher in 1 and Spain in 2.
Head to head by decade
| Decade | Netherlands | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.9% | 55.8% | 7.1% | Netherlands |
| 2010s | 77.7% | 83.5% | 5.8% | Spain |
| 2020s | 86.0% | 87.0% | 1.0% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Netherlands or Spain?
- Netherlands, at 89.0% against 89.0% in Spain as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Netherlands and Spain?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Spain?
- 23 years are reported by both, from 2000 to 2022.
- How do Netherlands and Spain rank globally for access to anti-retroviral drugs, female?
- Netherlands ranks 35th and Spain ranks 35th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.